First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

詳細情報 詳細情報について

• CRID

  1363670320721553024

• DOI

  10.1016/s1470-2045(12)70412-6

• ISSN

  14702045

• Web Site

  https://api.elsevier.com/content/article/PII:S1470204512704126?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1470204512704126?httpAccept=text/plain

• データソース種別

  • Crossref